Mast cell sarcoma: Clinical management

Catherine R. Weiler, Joseph Butterfield

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Mast cell sarcoma is a disorder that results in abnormal mast cells as identified by morphology, special stains, and in some publications, c-kit mutation analysis. It affects animal species such as canines more commonly than humans. In humans it is a very rare condition, with variable clinical presentation. There is no standard therapy for the disorder. It can affect any age group. It is occasionally associated with systemic mastocytosis and/or urticaria pigmentosa. The prognosis of mast cell sarcoma in published literature is very poor in humans.

Original languageEnglish (US)
Pages (from-to)423-432
Number of pages10
JournalImmunology and Allergy Clinics of North America
Volume34
Issue number2
DOIs
StatePublished - 2014

Fingerprint

Mast-Cell Sarcoma
Urticaria Pigmentosa
Systemic Mastocytosis
Mast Cells
Publications
Canidae
Coloring Agents
Age Groups
Mutation

Keywords

  • Clinical presentation of mast cell sarcoma
  • Mast cell sarcoma
  • Mastocytosis
  • Prognosis of mast cell sarcoma
  • Treatment of mast cell sarcoma

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Mast cell sarcoma : Clinical management. / Weiler, Catherine R.; Butterfield, Joseph.

In: Immunology and Allergy Clinics of North America, Vol. 34, No. 2, 2014, p. 423-432.

Research output: Contribution to journalArticle

Weiler, Catherine R. ; Butterfield, Joseph. / Mast cell sarcoma : Clinical management. In: Immunology and Allergy Clinics of North America. 2014 ; Vol. 34, No. 2. pp. 423-432.
@article{94527ce48e4d477daa78254d584a6d98,
title = "Mast cell sarcoma: Clinical management",
abstract = "Mast cell sarcoma is a disorder that results in abnormal mast cells as identified by morphology, special stains, and in some publications, c-kit mutation analysis. It affects animal species such as canines more commonly than humans. In humans it is a very rare condition, with variable clinical presentation. There is no standard therapy for the disorder. It can affect any age group. It is occasionally associated with systemic mastocytosis and/or urticaria pigmentosa. The prognosis of mast cell sarcoma in published literature is very poor in humans.",
keywords = "Clinical presentation of mast cell sarcoma, Mast cell sarcoma, Mastocytosis, Prognosis of mast cell sarcoma, Treatment of mast cell sarcoma",
author = "Weiler, {Catherine R.} and Joseph Butterfield",
year = "2014",
doi = "10.1016/j.iac.2014.01.004",
language = "English (US)",
volume = "34",
pages = "423--432",
journal = "Immunology and Allergy Clinics of North America",
issn = "0889-8561",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Mast cell sarcoma

T2 - Clinical management

AU - Weiler, Catherine R.

AU - Butterfield, Joseph

PY - 2014

Y1 - 2014

N2 - Mast cell sarcoma is a disorder that results in abnormal mast cells as identified by morphology, special stains, and in some publications, c-kit mutation analysis. It affects animal species such as canines more commonly than humans. In humans it is a very rare condition, with variable clinical presentation. There is no standard therapy for the disorder. It can affect any age group. It is occasionally associated with systemic mastocytosis and/or urticaria pigmentosa. The prognosis of mast cell sarcoma in published literature is very poor in humans.

AB - Mast cell sarcoma is a disorder that results in abnormal mast cells as identified by morphology, special stains, and in some publications, c-kit mutation analysis. It affects animal species such as canines more commonly than humans. In humans it is a very rare condition, with variable clinical presentation. There is no standard therapy for the disorder. It can affect any age group. It is occasionally associated with systemic mastocytosis and/or urticaria pigmentosa. The prognosis of mast cell sarcoma in published literature is very poor in humans.

KW - Clinical presentation of mast cell sarcoma

KW - Mast cell sarcoma

KW - Mastocytosis

KW - Prognosis of mast cell sarcoma

KW - Treatment of mast cell sarcoma

UR - http://www.scopus.com/inward/record.url?scp=84898829229&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84898829229&partnerID=8YFLogxK

U2 - 10.1016/j.iac.2014.01.004

DO - 10.1016/j.iac.2014.01.004

M3 - Article

C2 - 24745684

AN - SCOPUS:84898829229

VL - 34

SP - 423

EP - 432

JO - Immunology and Allergy Clinics of North America

JF - Immunology and Allergy Clinics of North America

SN - 0889-8561

IS - 2

ER -